Valuation: BML, Inc.

Market Cap 135B 825M 725M 674M 619M 1.16B 79.49B 1.18B 8.01B 3.13B 39.08B 3.1B 3.03B P/E 2027 *
17.9x
P/E 2028 * 15.6x
Enterprise Value 135B 825M 725M 674M 619M 1.16B 79.49B 1.18B 8.01B 3.13B 39.08B 3.1B 3.03B EV / Sales 2027 *
0.87x
EV / Sales 2028 * 0.84x
Free-Float
49.65%
Yield 2027 *
3.47%
Yield 2028 * 3.88%
1 day+4.59%
6 months+4.59%
Current year+0.99%
Current year 24.1
Extreme 24.1
25.21
1 year 24.1
Extreme 24.1
25.21
3 years 18.2
Extreme 18.2
25.21
5 years 18.2
Extreme 18.2
25.21
10 years 18.2
Extreme 18.2
25.21
Manager TitleAgeSince
President 59 2013-12-31
Corporate Officer/Principal 60 2020-03-31
Corporate Officer/Principal 66 2014-03-31
Director TitleAgeSince
Director/Board Member 59 2006-05-31
Director/Board Member 64 2016-05-31
Director/Board Member 67 2025-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.59%-.--% - - 814M
-1.26%-1.61%+87.24%+470.15% 37.52B
+0.23%+5.86%+13.78%+37.92% 24.34B
+0.85%-2.19%-23.76%-39.14% 7.33B
+0.55%+1.47%+6.47%+87.71% 4.84B
+3.87%+8.28%+18.76%+51.22% 3.05B
-4.07%-6.74%+105.57%-19.32% 1.81B
+1.81%+0.27%-12.74%-62.95% 1.78B
+1.80%-1.40%-29.57%+727.11% 1.75B
+7.21%-0.30%+14.49%+4.36% 1.74B
Average +1.56%-1.48%+20.03%+139.67% 9.35B
Weighted average by Cap. -0.06%-0.65%+43.54%+237.55%

Financials

2027 *2028 *
Net sales 155B 947M 832M 774M 710M 1.33B 91.24B 1.35B 9.19B 3.59B 44.86B 3.56B 3.48B 160B 979M 860M 799M 734M 1.38B 94.24B 1.4B 9.49B 3.71B 46.33B 3.67B 3.59B
Net income 7.4B 45.21M 39.7M 36.92M 33.88M 63.66M 4.35B 64.64M 438M 171M 2.14B 170M 166M 8.2B 50.09M 44M 40.92M 37.55M 70.55M 4.82B 71.63M 486M 190M 2.37B 188M 184M
Net Debt - -
Logo BML, Inc.
BML Inc is a Japan-based company primarily engaged in the testing business. Data processed in the host core system is reported to customers as test results. Customer unit price data and specimen testing performance data held by the host core system become billing data for customers, which is then linked to the automatic recording of sales. Other businesses include the medical information systems business. The testing business segment undertakes contract work such as clinical testing, while the medical information systems business segment manufactures and sells system equipment for medical institutions and provides medical information services.
Employees
4,612
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,605.00JPY
Average target price
3,800.00JPY
Spread / Average Target
+5.41%

Quarterly revenue - Rate of surprise